An Randomized, Multicenter, Open-label, Phase III Trial Comparing Neoadjuvant Chemoradiotherapy Versus Chemotherapy in Patients With Locally Advanced Gastric Adenocarcinoma
Phase of Trial: Phase III
Latest Information Update: 22 Nov 2018
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin (Primary)
- Indications Adenocarcinoma; Gastric cancer
- Focus Therapeutic Use
- Acronyms Neo-CRAG
- 29 Aug 2018 Planned End Date changed from 1 Jun 2022 to 1 Dec 2025.
- 29 Aug 2018 Planned primary completion date changed from 1 Jun 2022 to 1 Dec 2023.
- 30 Mar 2013 New trial record